IP Library Patent Application 16138555
Patent Application
App. No. 16/138,555

DIAGNOSTIC METHOD FOR URINARY TRACT INFECTION

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
16/138,555
Abstract

It has been demonstrated that the urinary level of HBP increases in individuals that have a urinary tract infection. Accordingly, the urinary level of HBP in an individual can be used to determine whether or not an individual has a urinary tract infection.

Claims (14)

1 - 14 . (canceled)

15 . A method of identifying whether an individual has a urinary tract infection (UTI), comprising:

measuring the level of Heparin Binding Protein (HBP, CAP37, Azuricidin) in a urine sample obtained from an individual by;

(i) contacting the sample with an antibody which binds specifically to HBP; and

(ii) quantitating the amount of antibody-HBP complex to measure the HBP level in the urine sample; and

detecting the presence of UTI in the individual at about 93% Sensitivity or greater and at about 90% Specificity or greater based on the measured HBP level in the urine sample.

16 . The method of claim 15 , wherein the individual is a mammal.

17 . The method of claim 16 , wherein the mammal is a human.

18 . The method of claim 17 , wherein the detecting of UTI at about 93% Sensitivity or greater and at about 90% Specificity or greater is determined by a Receiver Operating Characteristic (ROC).

19 . The method of claim 17 , wherein the 93.3% Sensitivity and the 90.3% Specificity for detecting UTI is a threshold value of about 32 ng/ml in the urine sample.

20 . The method of claim 15 , wherein the binding of the antibody to HBP is measured by enzyme linked immunosorbent assay (ELISA).

21 . The method of claim 15 , wherein the binding of the antibody to HBP is measured using a dipstick assay.

22 . The method of claim 15 , wherein the urinary tract infection is lower urinary tract infection or pyelonephritis.

23 . The method of claim 15 , further comprising determining the white blood cell count or the level of IL6 in a urine sample from the individual, or conducting the nitrite test on a urine sample from the individual.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 6, 2020
From: CHRISTENSSON, BERTIL; LINDER, ADAM; AKESSON, PER; HERWALD, HEIKO; BJÖRCK, LARS
To: HANSA MEDICAL AB
Reel/Frame 051422/0711 →
CHANGE OF NAME Recorded Jan 6, 2020
From: HANSA MEDICAL AB
To: HANSA BIOPHARMA AB
Reel/Frame 051485/0654 →